---
DrugClass: "[[Immune Modulating Therapies]]"
SubClass: "[[Checkpoint inhibitors]]"
DrugClassAdverse: "[[Checkpoint inhibitors#Adverse Reactions]]"
DrugClassContra: "[[Checkpoint inhibitors#Contraindications]]"
BrandName: Alecensa
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "51"
KindleLinkChap: "[Chapter 51](kindle://book?action=open&asin=B09FRF11YJ&location=30282)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat: Tyrosine Kinase/EGFR Inhibitors
---
```smiles
CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Solid tumors: lung 


### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Same reaction for [[acute lymphoblastic leukemia]] [[Boxes/Temple College Nursing Program/LVN Program/Fall 24/Pharmacology/Drugs/Drugs|Drugs]] in this category

### Interactions

`= this.ChemLink+this.file.name`

